Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Cocaine-Related Disorders · Cocaine Dependence · DRUG

BRIGHT MINDS BIOSCIENCES

BRIGHT MINDS BIOSCIENCES INC.

BRIGHT MINDS BIOSCIENCES clinical programs — 327 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
19 Vestry St, New York, NY 10013, US HQ
12 Employees
Public company Type
DRUG · NYSE Ticker
Company details
Status
Public
HQ
19 Vestry St, New York, NY 10013, US
Employees
12
Programs
1063
Drugs
444
Patents
57
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

BRIGHT MINDS BIOSCIENCES projects

327 ClinicalTrials.gov programs sponsored by BRIGHT MINDS BIOSCIENCES.

BRIGHT MINDS BIOSCIENCES has 327 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

327 programs

Clinical programs

Page 4 of 7

  1. Marinol 10Mg Capsule TMS Sham

    BRIGHT MINDS BIOSCIENCES INC.

    Neurosciences

    phase 1 small molecule completed

    1 trial

  2. Medium THC

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Impairment

    phase 1 small molecule completed

    1 trial

  3. Memantine

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 1 small molecule completed

    1 trial

  4. Meningococcal ACYW135 Polysaccharide Conjugate Vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    Meningitis, Meningococcal

    phase 1 mab active

    1 trial

  5. Mepolizumab

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Subjects

    phase 1 mab completed

    1 trial

  6. Methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate-Related Disorders

    phase 1 small molecule completed

    1 trial

  7. Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Stimulant Use

    phase 1 small molecule completed

    1 trial

  8. Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Use Disorder

    phase 1 small molecule completed

    1 trial

  9. Methamphetamine (Desoxyn®)

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Abuse

    phase 1 small molecule completed

    1 trial

  10. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorder

    phase 1 small molecule active

    1 trial

  11. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    1 trial

  12. Metronidazole gel 1

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  13. Mindful Awareness in Body-oriented Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorder

    phase 1 other completed

    1 trial

  14. Mindfulness Training for Smokers

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 other completed

    1 trial

  15. Mindfulness-Oriented Recovery Enhancement

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 1 other completed

    1 trial

  16. Minnelide™Capsules

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  17. Modafinil and Escitalopram

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  18. Mometasone furoate drug formulation (MFF) 1

    BRIGHT MINDS BIOSCIENCES INC.

    Hypersensitivity

    phase 1 small molecule completed

    1 trial

  19. Morphine Sulfate

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule active

    1 trial

  20. Motivational Interviewing

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    phase 1 other completed

    1 trial

  21. Motivational Network Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use

    phase 1 other completed

    1 trial

  22. Multi-media WINGS

    BRIGHT MINDS BIOSCIENCES INC.

    Intimate Partner Violence

    phase 1 other completed

    1 trial

  23. Mycophenolate Mofetil

    BRIGHT MINDS BIOSCIENCES INC.

    Hematopoietic Stem Cell Transplantation

    phase 1 small molecule active

    1 trial

  24. N-acetyl cysteine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  25. ND-003 40mg

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule active

    1 trial

  26. NDX-1017

    BRIGHT MINDS BIOSCIENCES INC.

    Alzheimer Disease

    phase 1 small molecule completed

    1 trial

  27. NP-G2-044

    BRIGHT MINDS BIOSCIENCES INC.

    Breast Cancer

    phase 1 small molecule completed

    1 trial

  28. NRS-033

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  29. NT-301 1 mg

    BRIGHT MINDS BIOSCIENCES INC.

    Tolerability of NT-301 Nasal Spray

    phase 1 other completed

    1 trial

  30. NX210c

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Elderly

    phase 1 small molecule completed

    1 trial

  31. Nafamostat Mesilate

    BRIGHT MINDS BIOSCIENCES INC.

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  32. Nalmefene

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 1 small molecule completed

    1 trial

  33. Naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 1 small molecule completed

    1 trial

  34. Naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Overdose

    phase 1 small molecule completed

    1 trial

  35. Naloxone Hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 1 small molecule terminated

    1 trial

  36. Naltrexone and Bupropion SR

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 1 small molecule completed

    1 trial

  37. Naltrexone implant, 14.4 grams

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule active

    1 trial

  38. Narcan 40 MG/ML Nasal Spray

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Induced Respiratory Depression

    phase 1 small molecule active

    1 trial

  39. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 small molecule completed

    1 trial

  40. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Addiction

    phase 1 small molecule completed

    1 trial

  41. Nicotine (Pharmaceutical Productions Inc.)

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Pharmacokinetic Study

    phase 1 small molecule completed

    1 trial

  42. Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    phase 1 small molecule completed

    1 trial

  43. Nicotine Pouches

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Pouch Self-Administration

    phase 1 small molecule active

    1 trial

  44. Nicotine Replacement Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 1 small molecule completed

    1 trial

  45. Nicotine nasal spray 0.5 mg

    BRIGHT MINDS BIOSCIENCES INC.

    Adverse Childhood Experiences

    phase 1 small molecule active

    1 trial

  46. Nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    phase 1 small molecule completed

    1 trial

  47. Nicotine polacrilex

    BRIGHT MINDS BIOSCIENCES INC.

    Depressive Disorder

    phase 1 small molecule completed

    1 trial

  48. Nicotine saline infusion 0.00mcg/kg/s

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does BRIGHT MINDS BIOSCIENCES have?

327 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.